Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar TomFoolNC (95.66) Submitted: 9/18/2011 11:25:48 PM : Outperform Start Price: $41.13 VRX Score: +7.35

picks its spots, Bob Goldfarb

Featured Broker Partners


Advertisement